¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive thrombus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive bulbar palsy
    ÁøÇà¼û³ú¸¶ºñ, ÁøÇ࿬¼ö¸¶ºñ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½É±Ùº´Èæ»öÁ¡Áõ
  • progressive case
    ÁøÇ༺¿¹
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇ༺»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇ༺°ñ°£Çü¼ºÀÌ»ó
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive external ophthalmoplegia
    ÁøÇà¹Ù±ù´«±ÙÀ°¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°, ÁøÇàºñ´ë°£Áú½Å°æ¿°
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é(»ö)Áú³úº´(Áõ)
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • idiopathic progressive atrophoderma
    ¿øÀκҸíÁøÇàÇǺÎÀ§ÃàÁõ
  • neural progressive muscular atrophy
    ½Å°æÁøÇà±ÙÀ°À§Ãà
  • progressive spinal amyotrophy
    ÁøÇàô¼ö±ÙÀ°À§ÃàÁõ
  • chronic progressive disciform granulomatosis
    ¸¸¼ºÁøÇà¿ø¹ÝÀ°¾ÆÁ¾Áõ
  • progressive case
    ÁøÇ༺¿¹
  • essential progressive deafness
    Ư¹ßÁøÇ೭û
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇà»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇà°ñ°£Çü¼ºÀÌ»ó
  • progressive muscular dystrophy
    ÁøÇà±ÙÀ°ÅðÇàÀ§Ãà
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´Áõ
  • familial progressive hearing loss
    °¡Á·ÁøÇ೭û
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • malignant progressive histiocytoma
    ¾Ç¼ºÁøÇàÁ¶Á÷±¸Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive diaphyseal dysplasia
    ÁøÇ༺ °ñ°£¼º ÀÌÇü¼º(Áõ)(òäú¼àõ ÍéÊÏàõ ì¶û¡à÷(ñø))
  • progressive diffuse keratoderma
    ÁøÇ༺ ±¤¹üÀ§ °¢ÇÇÁõ
  • progressive external ophthalmoplegia
    ÁøÇ༺¿Ü¾È±Ù¸¶ºñ
  • progressive facial paralysis
    ÁøÇà(¼º) ¾È¸é¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(¡­ãêÌèæú).
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
  • progressive idiopathic atrophoderma
    ÁøÇ༺ ¿øÀÎºÒ¸í¼º ÇǺΠÀ§ÃàÁõ
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • progressive lingual hemiatrophy
    ÁøÇà(¼º) ¹ÝÃø¼³À§ÃàÁõ
  • progressive lingual hemiatrophy
    ÁøÇ༺ ¹ÝÃø¼³À§ÃàÁõ(òäú¼àõ Úâö°àßê×õêñø)
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´Ù¹ß¼º ¹éÁú³ú(º´)Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú³úº´Áõ(òäú¼àõ Òýõ¥ïÇàõ ÛÜòõÒàÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mural thrombus
    º®ÀçÇ÷ÀüÁõ(Ûúî¤úìîûñø) ¡ì½ÉÀåÀÇ¡í.
  • obstructive thrombus
    Æó¼â¼º Ç÷Àü(¡­úìîû).
  • obstructive thrombus
    Æó¼â¼º Ç÷Àü(¡­Ç÷Àü).
  • organized thrombus
    ±âÁúÈ­Ç÷Àü(Ѩòõûùúìï°)
  • red thrombus
    Àû»öÇ÷Àü(îåßäúìîû)
  • separating thrombus
    ºÐ¸®Ç÷Àü(¡­úìîû).
  • separating thrombus
    ºÐ¸®Ç÷Àü(¡­úìîû)
  • thrombus
    Ç÷Àü
  • thrombus
    Ç÷Àü(úìîû)
  • thrombus formation
    Ç÷ÀüÇü¼º(úìîûû¡à÷)
  • thrombus,dissolution of
    ¡­ÀÇ ¿ëÇØ, ¡­ÀÇ ºÐÇØ(ÝÂú°)
  • thrombus,mural
    º®(ÀÇ), º®À缺(ÀÇ)
  • thrombus,occlusive
    Æó»ö¼º(øÍßáàõ)
  • thrombus,propagating
    ÀüÆÄ¼º
  • thrombus,recanalization
    Àç¼ÒÅë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ICT icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int...
LAT lateral; latex agglutination test; left atrial thrombus; lysolecithin acyltransferase
TFT thin-film transistor; thrombus formation time; thyroid function test; tight filum terminale; trifluo...
throm, thromb thrombosis, thrombus
TT tablet triturate; tactile tension; tendon transfer; test tube; testicular torsion; tetanus toxin; te...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PFIC Progressive Familial Intrahepatic Cholestasis
PMF Progressive Massive Fibrosis
PML Progressive Multifocal Leucoencephalopathy
PMR Progressive Muscle Relaxation
PME Progressive Myoclonus Epilepsy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • progressive dystrophic ophthalmoplegia
    ÁøÇ༺ ÀÌ¿µ¾ç¼º ¾È±Ù ¸¶ºñ
  • progressive focal neurologic disturbance
    ÁøÇ༺ ±¹¼ÒÀû ½Å°æÇÐÀû Àå¾Ö
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú ³úº´Áõ
  • progressive muscular dystrophy
    ÁøÇ༺ ±Ù ÀÌ¿µ¾çÁõ
  • progressive myopia
    ÁøÇ༺ ±Ù½Ã
  • progressive paralysis
    ÁøÇ༺ ¸¶ºñ
    ¸Åµ¶¿¡ °¨¿°µÈ ÈÄ 3¡­40³â
  • progressive patient care
    ´Ü°èÀû ȯÀÚ °ü¸®
  • progressive relaxation tape
    Á¡ÁøÀû ÀÌ¿Ï Å×ÀÌÇÁ
  • progressive resistance
    Á¡Áõ ÀúÇ×
  • progressive scleroderma
    ÁøÇ༺ °øÇÇÁõ
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±Ù À§ÃàÁõ
  • progressive supranuclear palsy
    ÁøÇ༺ ÇÙ»ó ¸¶ºñ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • symmetrical progressive erythrokeratoderma
    ´ëμº ÁøÇ༺ È«¹Ý °¢ÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
postmortem thrombus A clot formed within the heart or in a blood vessel after death.
(05 Mar 2000)
propagated thrombus A gradually increasing thrombosis involving one section of a vein after another in continuity.
(05 Mar 2000)
secondary thrombus A thrombus formed about an embolus as a nucleus.
(05 Mar 2000)
hyaline thrombus A translucent colourless plug, partly or wholly filling a capillary or small artery or vein, formed by agglutination of red blood corpuscles.
Synonym: agglutinative thrombus.
(05 Mar 2000)
stratified thrombus A laminated thrombus, the layers of different ages being of different colour or consistency.
Synonym: stratified thrombus.
(05 Mar 2000)
infective thrombus A thrombus formed in septic phlebitis.
(05 Mar 2000)
obstructive thrombus A thrombus due to obstruction in the vessel from compression or other cause.
(05 Mar 2000)
thrombus <haematology> An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation. Some authorities thus differentiate thrombus formation from simple coagulation or clot formation.
Compare: embolism.
Origin: Gr. Thrombos = clot
(18 Nov 1997)
fibrin thrombus A thrombus formed by repeated deposits of fibrin from the circulating blood; it usually does not completely occlude the vessel.
(05 Mar 2000)
laminated thrombus A thrombus formed gradually by clotting of the blood in successive layers.
(05 Mar 2000)
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
bovine progressive degenerative myeloencephalopathy A familiar myeloencephalopathy of brown Swiss cattle characterised by bilateral hindleg weakness and ataxia and deficient proprioceptive reflexes.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
chronic progressive chorea A progressive disorder usually beginning in young to middle age, consisting of a triad of choreoathetosis, dementia, and autosomal dominant inheritance with complete penetrance. Bilateral marked wasting of the putamen and the head of the caudate nucleus is characteristic.
Synonym: chronic progressive chorea, degenerative chorea, hereditary chorea, Huntington's disease.
(05 Mar 2000)
chronic progressive external ophthalmoplegia A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á